FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2087099395> ?p ?o ?g. }

• W2087099395 endingPage "297" @default.
• W2087099395 startingPage "287" @default.
• W2087099395 abstract "The mechanisms by which environmental influences lead to the development of complex neurodegenerative diseases are largely unknown. It is known, however, that epigenetic mechanisms can mediate alterations in transcription due to environmental influences. In order to identify genes susceptible to regulation in the adult cortex by one type of epigenetic mechanism, histone, and protein acetylation, we treated mice with the histone deacetylase inhibitor Trichostatin A (TSA). After 1 week of treatment with TSA, RNA was extracted from the brain cortices of mice and gene expression differences were analyzed by microarray profiling. The altered genes were then compared with genes differentially expressed in microarray studies of disease by database and literature searches. Genes regulated by TSA were found to significantly overlap with differentially expressed genes in the Alzheimer's disease (AD) brain. Several TSA-regulated genes involved in chromatin remodeling and epigenetic reprogramming including histone cluster 1, H4 h (Hist1H4 h), methionine adenosyltransferase II, alpha (Mat2a), and 5-methyltetrahydrofolate homocysteine reductase (Mtrr) overlapped with genes altered in early-stage AD in gray matter. We also show that the expression of hemoglobin, which has been shown to be altered in neurons in the AD brain, is regulated by TSA treatment. This analysis suggests involvement of epigenetic mechanisms in neurons in early stages of AD." @default.
• W2087099395 created "2016-06-24" @default.
• W2087099395 creator A5002238122 @default.
• W2087099395 creator A5037530353 @default.
• W2087099395 creator A5038255733 @default.
• W2087099395 creator A5060917386 @default.
• W2087099395 creator A5084748465 @default.
• W2087099395 date "2012-07-19" @default.
• W2087099395 modified "2023-09-26" @default.
• W2087099395 title "Transcriptional signatures mediated by acetylation overlap with early-stage Alzheimer’s disease" @default.
• W2087099395 cites W1494932082 @default.
• W2087099395 cites W1662308449 @default.
• W2087099395 cites W1878700164 @default.
• W2087099395 cites W190924719 @default.
• W2087099395 cites W1967117492 @default.
• W2087099395 cites W1970028828 @default.
• W2087099395 cites W1975460771 @default.
• W2087099395 cites W1977813572 @default.
• W2087099395 cites W1995550632 @default.
• W2087099395 cites W1997838879 @default.
• W2087099395 cites W1998949081 @default.
• W2087099395 cites W2003115630 @default.
• W2087099395 cites W2005889734 @default.
• W2087099395 cites W2011718960 @default.
• W2087099395 cites W2013037750 @default.
• W2087099395 cites W2014272598 @default.
• W2087099395 cites W2015522247 @default.
• W2087099395 cites W2016777985 @default.
• W2087099395 cites W2021289158 @default.
• W2087099395 cites W2023437193 @default.
• W2087099395 cites W2027315046 @default.
• W2087099395 cites W2036362108 @default.
• W2087099395 cites W2039640602 @default.
• W2087099395 cites W2051075231 @default.
• W2087099395 cites W2051843178 @default.
• W2087099395 cites W2052742260 @default.
• W2087099395 cites W2058723245 @default.
• W2087099395 cites W2061035319 @default.
• W2087099395 cites W2061378782 @default.
• W2087099395 cites W2067215332 @default.
• W2087099395 cites W2073759231 @default.
• W2087099395 cites W2075161068 @default.
• W2087099395 cites W2076743693 @default.
• W2087099395 cites W2084210522 @default.
• W2087099395 cites W2086602114 @default.
• W2087099395 cites W2089616240 @default.
• W2087099395 cites W2089689396 @default.
• W2087099395 cites W2089740883 @default.
• W2087099395 cites W2090123666 @default.
• W2087099395 cites W2090481539 @default.
• W2087099395 cites W2090760765 @default.
• W2087099395 cites W2092597346 @default.
• W2087099395 cites W2093247513 @default.
• W2087099395 cites W2094301427 @default.
• W2087099395 cites W2097632269 @default.
• W2087099395 cites W2098089867 @default.
• W2087099395 cites W2098135062 @default.
• W2087099395 cites W2102650381 @default.
• W2087099395 cites W2102842633 @default.
• W2087099395 cites W2103102045 @default.
• W2087099395 cites W2103315169 @default.
• W2087099395 cites W2105090223 @default.
• W2087099395 cites W2105180380 @default.
• W2087099395 cites W2109112922 @default.
• W2087099395 cites W2111843532 @default.
• W2087099395 cites W2114729479 @default.
• W2087099395 cites W2116030076 @default.
• W2087099395 cites W2121264285 @default.
• W2087099395 cites W2130410032 @default.
• W2087099395 cites W2135482947 @default.
• W2087099395 cites W2135498007 @default.
• W2087099395 cites W2136407293 @default.
• W2087099395 cites W2142388403 @default.
• W2087099395 cites W2142755889 @default.
• W2087099395 cites W2146824244 @default.
• W2087099395 cites W2149591661 @default.
• W2087099395 cites W2154441086 @default.
• W2087099395 cites W2155833713 @default.
• W2087099395 cites W2157921593 @default.
• W2087099395 cites W2158747282 @default.
• W2087099395 cites W2165427528 @default.
• W2087099395 cites W2166336042 @default.
• W2087099395 cites W38497974 @default.
• W2087099395 doi "https://doi.org/10.1007/s00221-012-3172-y" @default.
• W2087099395 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3678955" @default.
• W2087099395 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22811216" @default.
• W2087099395 hasPublicationYear "2012" @default.
• W2087099395 type Work @default.
• W2087099395 sameAs 2087099395 @default.
• W2087099395 citedByCount "11" @default.
• W2087099395 countsByYear W20870993952013 @default.
• W2087099395 countsByYear W20870993952014 @default.
• W2087099395 countsByYear W20870993952015 @default.
• W2087099395 countsByYear W20870993952016 @default.
• W2087099395 countsByYear W20870993952017 @default.
• W2087099395 countsByYear W20870993952020 @default.
• W2087099395 countsByYear W20870993952021 @default.
• W2087099395 crossrefType "journal-article" @default.

• next